HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kovalev, G. I. Articles by Su, L. Search for Related Content PubMed PubMed Citation Articles by Kovalev, G. I. Articles by Su, L. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH

An Important Role of CDK Inhibitor p18^INK4c in Modulating Antigen Receptor-Mediated T Cell Proliferation¹

Grigoriy I. Kovalev^*,, David S. Franklin^2,*,, V. McNeil Coffield^*,, Yue Xiong^*, and Lishan Su^3,*,

^* Lineberger Comprehensive Cancer Center, Departments of Microbiology and Immunology, and Biochemistry and Biophysics, School of Medicine, University of North Carolina, Chapel Hill, NC 27599

The inhibitors of cyclin-dependent kinase (CDK) 4 (INK4) bind CDK4/6 to prevent their association with D-cyclins and G₁ cell cycle initiation and progression. We report here that among the seven CDK inhibitors, p18^INK4c played an important role in modulating TCR-mediated T cell proliferation. Loss of p18^INK4c in T cells led to hyperproliferation in response to CD3 stimulation. p18^INK4c-null mice developed lymphoproliferative disorder and T cell lymphomas. Expression of IL-2, IL-2R-, and the major G₁ cell cycle regulatory proteins was not altered in p18-null T cells. Both FK506 and rapamycin efficiently inhibited proliferation of p18-null T cells. In activated T cells, p18^INK4c remained constant, and preferentially associated with and inhibited CDK6 but not CDK4. We propose that p18^INK4c sets an inhibitory threshold in T cells and one function of CD28 costimulation is to counteract the p18^INK4c inhibitory activity on CDK6-cyclin D complexes. The p18^INK4c protein may provide a novel target to modulate T cell immunity.

This article has been cited by other articles:

				X. Lu, G. I. Kovalev, H. Chang, E. Kallin, G. Knudsen, L. Xia, N. Mishra, P. Ruiz, E. Li, L. Su, et al. Inactivation of NuRD Component Mta2 Causes Abnormal T Cell Activation and Lupus-like Autoimmune Disease in Mice J. Biol. Chem., May 16, 2008; 283(20): 13825 - 13833. [Abstract] [Full Text] [PDF]

				N. Marzo, S. Ortega, T. Stratmann, A. Garcia, M. Rios, A. Gimenez, R. Gomis, and C. Mora Cyclin-Dependent Kinase 4 Hyperactivity Promotes Autoreactivity in the Immune System but Protects Pancreatic Cell Mass from Autoimmune Destruction in the Nonobese Diabetic Mouse Model J. Immunol., January 15, 2008; 180(2): 1189 - 1198. [Abstract] [Full Text] [PDF]

				A. B. Borowski, A. C. Boesteanu, Y. M. Mueller, C. Carafides, D. J. Topham, J. D. Altman, S. R. Jennings, and P. D. Katsikis Memory CD8+ T Cells Require CD28 Costimulation J. Immunol., November 15, 2007; 179(10): 6494 - 6503. [Abstract] [Full Text] [PDF]

				D. Holmes, G. Knudsen, S. Mackey-Cushman, and L. Su FoxP3 Enhances HIV-1 Gene Expression by Modulating NF{kappa}B Occupancy at the Long Terminal Repeat in Human T Cells J. Biol. Chem., June 1, 2007; 282(22): 15973 - 15980. [Abstract] [Full Text] [PDF]

				Y. Yuan, H. Yu, M. J. Boyer, X. Song, S. Cao, H. Shen, and T. Cheng Hematopoietic Stem Cells Are Not the Direct Target of Spontaneous Leukemic Transformation in p18INK4C-Null Reconstituted Mice Cancer Res., January 1, 2006; 66(1): 343 - 351. [Abstract] [Full Text] [PDF]

				E. A. Rowell, M. C. Walsh, and A. D. Wells Opposing Roles for the Cyclin-Dependent Kinase Inhibitor p27kip1 in the Control of CD4+ T Cell Proliferation and Effector Function J. Immunol., March 15, 2005; 174(6): 3359 - 3368. [Abstract] [Full Text] [PDF]

				L. A. Wolfraim and J. J. Letterio Cutting Edge: p27Kip1 Deficiency Reduces the Requirement for CD28-Mediated Costimulation in Naive CD8+ but Not CD4+ T Lymphocytes J. Immunol., March 1, 2005; 174(5): 2481 - 2484. [Abstract] [Full Text] [PDF]

				G. Li, J. Domenico, J. J. Lucas, and E. W. Gelfand Identification of Multiple Cell Cycle Regulatory Functions of p57Kip2 in Human T Lymphocytes J. Immunol., August 15, 2004; 173(4): 2383 - 2391. [Abstract] [Full Text] [PDF]

				A. Sanchez-Aguilera, J. Delgado, F. I. Camacho, M. Sanchez-Beato, L. Sanchez, C. Montalban, M. F. Fresno, C. Martin, M. A. Piris, and J. F. Garcia Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas Blood, March 15, 2004; 103(6): 2351 - 2357. [Abstract] [Full Text] [PDF]

				T. C. Gebuhr, G. I. Kovalev, S. Bultman, V. Godfrey, L. Su, and T. Magnuson The Role of Brg1, a Catalytic Subunit of Mammalian Chromatin-remodeling Complexes, in T Cell Development J. Exp. Med., December 15, 2003; 198(12): 1937 - 1949. [Abstract] [Full Text] [PDF]

				H. A. Doyle, R. J. Gee, and M. J. Mamula A Failure to Repair Self-Proteins Leads to T Cell Hyperproliferation and Autoantibody Production J. Immunol., September 15, 2003; 171(6): 2840 - 2847. [Abstract] [Full Text] [PDF]

				N. C. Lea, S. J. Orr, K. Stoeber, G. H. Williams, E. W.-F. Lam, M. A. A. Ibrahim, G. J. Mufti, and N. S. B. Thomas Commitment Point during G0->G1 That Controls Entry into the Cell Cycle Mol. Cell. Biol., April 1, 2003; 23(7): 2351 - 2361. [Abstract] [Full Text] [PDF]

				F. Bai, X.-H. Pei, V. L. Godfrey, and Y. Xiong Haploinsufficiency of p18INK4c Sensitizes Mice to Carcinogen-Induced Tumorigenesis Mol. Cell. Biol., February 15, 2003; 23(4): 1269 - 1277. [Abstract] [Full Text] [PDF]

				A. Blais, D. Monte, F. Pouliot, and C. Labrie Regulation of the Human Cyclin-dependent Kinase Inhibitor p18INK4c by the Transcription Factors E2F1 and Sp1 J. Biol. Chem., August 23, 2002; 277(35): 31679 - 31693. [Abstract] [Full Text] [PDF]